Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes

Science

Volumn 335, Issue 6074, 2012, Pages 1376-1380

  Cobey, Sarah ^a   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIGEN; BACTERIUM; COEXISTENCE; COLONIZATION; FITNESS; IMMUNE RESPONSE; IMMUNITY; VACCINATION;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL COLONIZATION; HUMAN; IMMUNE RESPONSE; MICROBIAL DIVERSITY; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

STREPTOCOCCUS PNEUMONIAE;

EID: 84858339217     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1215947     Document Type: Article

References (32)

1. G. E. Hutchinson, Quant. Bio. 22, 415 (1957).
2. P. Chesson, Annu. Rev. Ecol. Syst. 31, 343 (2000).
3. C. O. Buckee, P. C. Bull, S. Gupta, Proc. Biol. Sci. 276, 477 (2009).
4. K. Koelle, S. Cobey, B. Grenfell, M. Pascual, Science 314, 1898 (2006).
5. C. O. Buckee, S. Gupta, P. Kriz, M. C. Maiden, K. A. Jolley, Proc. Biol. Sci. 277, 1635 (2010).
6. S. Gupta, N. M. Ferguson, R. M. Anderson, Science 280, 912 (1998).
7. K. L. O'Brien et al., Lancet 374, 893 (2009).
8. L. Högberg et al., J. Clin. Microbiol. 45, 948 (2007).
9. M. Lipsitch et al., Epidemiology 10.1097/EDE. 0b013e31824f2f32 (2012).
10. D. M. Weinberger et al., PLoS Pathog. 5, e1000476 (2009).
11. D. M. Weinberger et al., J. Infect. Dis. 197, 1511 (2008).
12. P. C. Hill et al., Clin. Infect. Dis. 46, 807 (2008).
13. D. Goldblatt et al., J. Infect. Dis. 192, 387 (2005).
14. M. Lipsitch, C. Colijn, T. Cohen, W. P. Hanage, C. Fraser, Epidemics 1, 2 (2009).
15. M. Lipsitch et al., Vaccine 18, 2895 (2000).
16. E. S. Lysenko, R. S. Lijek, S. P. Brown, J. N. Weiser, Curr. Biol. 20, 1222 (2010).
17. B. M. Gray, G. M. Converse 3rd, H. C. Dillon Jr., J. Infect. Dis. 142, 923 (1980).
18. Y. J. Lu et al., PLoS Pathog. 4, e1000159 (2008).
19. R. Malley et al., Proc. Natl. Acad. Sci. U.S.A. 102, 4848 (2005).
20. O. Abdullahi, J. Nyiro, P. Lewa, M. Slack, J. A. Scott, Pediatr. Infect. Dis. J. 27, 59 (2008).
21. W. P. Hausdorff, J. Bryant, C. Kloek, P. R. Paradiso, G. R. Siber, Clin. Infect. Dis. 30, 122 (2000).
22. Z. B. Harboe et al., Clin. Infect. Dis. 50, 329 (2010).
23. H. Rinta-Kokko, R. Dagan, N. Givon-Lavi, K. Auranen, Vaccine 27, 3831 (2009).
24. W. P. Hanage et al., Epidemics 2, 80 (2010).
25. S. Flasche et al., PLoS Med. 8, e1001017 (2011).
26. X. Yu et al., J. Infect. Dis. 180, 1569 (1999).
27. A. R. McLean, Br. Med. Bull. 54, 545 (1998).
28. M. Lipsitch, Proc. Natl. Acad. Sci. U.S.A. 94, 6571 (1997).
29. A. Melegaro, Y. Choi, R. Pebody, N. Gay, Am. J. Epidemiol. 166, 228 (2007).
30. C. L. Trotter, N. J. Gay, W. J. Edmunds, Am. J. Epidemiol. 162, 89 (2005).
31. R. MacArthur, R. Levins, Am. Nat. 101, 377 (1967).
32. P. B. Adler, J. Hillerislambers, J. M. Levine, Ecol. Lett. 10, 95 (2007).